HKHugh I. Kim

Hugh I. Kim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hugh I. Kim has a total of 162 co-authors. Here are the top co-authors by number of shared publications:

  • Chae Eun Heo

    Department of Chemistry, Korea University, Seoul 02841, Republic of Korea

    12 shared publications
  • Jong Yoon Han

    Department of Chemistry, Korea University, Seoul 02841, Republic of Korea

    7 shared publications
  • Dongjoon Im

    Department of Chemistry Korea University Seoul 02841 Republic of Korea

    6 shared publications
  • Hyun Hee L. Lee

    Department of Chemistry, Korea University, Seoul 02841, Republic of Korea

    6 shared publications
  • Jeeyoung Lee

    Department of Biochemistry and Molecular Biology Seoul National University College of Medicine Seoul 03080 South Korea

    6 shared publications
  • Tae Su Choi

    Department of Life Sciences, Korea University, Seoul 02841, Republic of Korea

    6 shared publications

Latest Publications

  • Open Access

    Antiparallel β ‐Sheet as a Key Motif of Amyloid‐ β Inhibitor Designed via Topological Peptide Reprogramming

    by Dongjoon Im, Ye Eun Lee, Gyusub Yoon, William A. Goddard, Tae Su Choi, Hugh I. Kim

    Peptide inhibitor design targeting self‐assembly of amyloid‐ β (A β ) represents a promising strategy for suppressing the pathogenic mechanism of Alzheimer's disease (AD). Conventional approaches have primarily mimicked repetitive sequences found in fibrillar structures of A β aggregates. However, since the inherent flexibility of A β structures promotes the structural changes in the early‐stage oligomerization, a structural modulation should be considered in the design of peptide inhibitors. Herein, we introduce topological reprogramming of peptides to control the structural transformation in pathogenic A β 1–42 (A β 42). The eleven‐residue peptide scaffold P a11 ( 14 HQKLVNFAEDV 24 ) identified through the initial screening was dimerized via a disulfide bond. The dimerization stabilizes A β 42 into higher order structures by promoting antiparallel β ‐sheet conformations, thereby significantly suppressing A β 42 aggregation. Our approach underscores that modification in peptide connectivity would be a breakthrough for controlling the intrinsic flexibility of A β , surpassing the limitation in conventional, one‐dimensional peptide building block.


  • Open Access

    Mechanisms of chemotherapy failure in refractory/relapsed acute myeloid leukemia: the role of cytarabine resistance and mitochondrial metabolism

    by Soo Yeon Chae, Se-Young Jang, Jinhui Kim, Sehyun Hwang, Disha Malani, Olli Kallioniemi, Seung Gyu Yun, Jong-Seo Kim, Hugh I. Kim

    Acute myeloid leukemia (AML) is an aggressive hematological malignancy. Patients with wild-type FLT3 relapsed or refractory (R/R) AML face significant therapeutic challenges due to the persistent lack of effective treatments. A comprehensive understanding of the mechanisms underlying chemotherapy resistance is needed to the development of effective treatment strategies. Therefore, we investigated the molecular mechanisms underlying cytarabine (Ara-C) resistance and daunorubicin (DNR) tolerance in Ara-C-resistant RHI-1 cells derived from the wild-type FLT3 AML cell line SHI-1. Quantitative analysis of intracellular drug concentrations, proteomics, and phosphoproteomics showed that DNR resistance in Ara-C-resistant RHI-1 cells is driven by metabolic remodeling toward mitochondrial metabolism, upregulation of DNA repair pathways, and enhanced reactive oxygen species (ROS) detoxification rather than reduced drug uptake. Moreover, targeting these compensatory mechanisms, particularly the OXPHOS complex I proteins, significantly improved the efficacy of both Ara-C and DNR. Conclusively, these findings highlight mitochondrial metabolism and DNA repair as critical factors in chemotherapy resistance and offer valuable insights into potential therapeutic targets for enhancing treatment outcomes in patients with wild-type FLT3 R/R AML.


  • Accelerated Amyloid Aggregation Dynamics of Intrinsically Disordered Proteins in Heavy Water

    by Myung Kook Son, Dongjoon Im, Da Gyeong Hyun, Soohyeong Kim, So Yeon Chun, Jeong-Mo Choi, Tae Su Choi, Minhaeng Cho, Kyungwon Kwak, Hugh I. Kim

    We explored the influence of D2O on the fibrillation kinetics and structural dynamics of amyloid intrinsically disordered proteins (IDPs), including α-synuclein, amyloid-β 1-42, and K18. Our findings revealed that fibrillation of IDPs was accelerated in D2O compared to that in H2O, exhibiting faster kinetics in contrast to the structured protein, insulin. Structural investigations using electrospray ionization ion mobility mass spectrometry and small-angle X-ray scattering combined with molecular dynamics simulations demonstrated that IDPs did not show significant structural changes that could influence accelerated fibrillation in D2O. Umbrella sampling of protein protofibrils verified that an increased level of hydrogen bonding of D2O and enhanced hydrophobic interactions stabilized β-sheet structured fibrils in D2O. These findings indicate that stabilizing β-sheet fibrils and a more hydrophobic microenvironment in D2O result in enhanced and faster fibrillation of IDPs. The study highlights the importance of considering D2O's differential impact on protein interactions when conducting structural and kinetic analyses, particularly for native peptides and proteins.


  • Open Access

    Spatiotemporal Nitric Oxide Modulation via Electrochemical Platform to Profile Tumor Cell Response

    by Chanju Won, Sojin Kim, Dongvin Kwak, Taemin Kim, Jinhui Kim, Eunjun Lee, Suyeon Kim, Ramakrishnan Velmurugan Adith, Stefan Ringe, Hugh I. Kim, et al.

    Nitric oxide (NO) is a gaseous molecule intricately implicated in oncologic processes, encompassing the modulation of angiogenesis and instigating apoptosis. Investigation of the antitumor effects of NO is currently underway, necessitating a detailed understanding of its cellular‐level reactions. Regulating the behavior of radical NO species has been a significant challenge, primarily due to its instability in aqueous environments by rapid O2‐induced degradation. In this study, we devised an electrochemical platform to investigate the cellular responses to reactive gaseous molecules. Our designed platform precisely controlled the NO flux and diffusion rates of NO to tumor cells. COMSOL Multiphysics calculations based on diffusion and reaction kinetics were conducted to simulate the behavior of electrochemically generated NO. We discerned that the effective radius, NO flux, and electrolysis duration are pivotal factors governing cellular response by NO.

  • Open Access

    Spatiotemporal Nitric Oxide Modulation via Electrochemical Platform to Profile Tumor Cell Response

    by Chanju Won, Sojin Kim, Dongvin Kwak, Taemin Kim, Jinhui Kim, Eunjun Lee, Suyeon Kim, Ramakrishnan Velmurugan Adith, Stefan Ringe, Hugh I. Kim, et al.

    Nitric oxide (NO) is a gaseous molecule intricately implicated in oncologic processes, encompassing the modulation of angiogenesis and instigating apoptosis. Investigation of the antitumor effects of NO is currently underway, necessitating a detailed understanding of its cellular‐level reactions. Regulating the behavior of radical NO species has been a significant challenge, primarily due to its instability in aqueous environments by rapid O2‐induced degradation. In this study, we devised an electrochemical platform to investigate the cellular responses to reactive gaseous molecules. Our designed platform precisely controlled the NO flux and diffusion rates of NO to tumor cells. COMSOL Multiphysics calculations based on diffusion and reaction kinetics were conducted to simulate the behavior of electrochemically generated NO. We discerned that the effective radius, NO flux, and electrolysis duration are pivotal factors governing cellular response by NO.


  • Open Access

    Genipin and pyrogallol: Two natural small molecules targeting the modulation of disordered proteins in Alzheimer's disease

    by Sujin Kim, Da Gyeong Hyun, Yunkwon Nam, Soo Jung Shin, Dongjoon Im, Hyeon Soo Kim, Seol Hwa Leem, Hyun Ha Park, Byeong-Hyeon Kim, Yong Ho Park, et al.


  • Open Access

    Self‐Aggregating Tau Fragments Recapitulate Pathologic Phenotypes and Neurotoxicity of Alzheimer's Disease in Mice

    by Ly Thi Huong Luu Le, Jeeyoung Lee, Dongjoon Im, Sunha Park, Kyoung‐Doo Hwang, Jung Hoon Lee, Yanxialei Jiang, Yong‐Seok Lee, Young Ho Suh, Hugh I. Kim, et al.

    In tauopathy conditions, such as Alzheimer's disease (AD), highly soluble and natively unfolded tau polymerizes into an insoluble filament; however, the mechanistic details of this process remain unclear. In the brains of AD patients, only a minor segment of tau forms β‐helix‐stacked protofilaments, while its flanking regions form disordered fuzzy coats. Here, it is demonstrated that the tau AD nucleation core (tau‐AC) sufficiently induced self‐aggregation and recruited full‐length tau to filaments. Unexpectedly, phospho‐mimetic forms of tau‐AC (at Ser324 or Ser356) show markedly reduced oligomerization and seeding propensities. Biophysical analysis reveal that the N‐terminus of tau‐AC facilitates the fibrillization kinetics as a nucleation motif, which becomes sterically shielded through phosphorylation‐induced conformational changes in tau‐AC. Tau‐AC oligomers are efficiently internalized into cells via endocytosis and induced endogenous tau aggregation. In primary hippocampal neurons, tau‐AC impaired axon initial segment plasticity upon chronic depolarization and is mislocalized to the somatodendritic compartments. Furthermore, it is observed significantly impaired memory retrieval in mice intrahippocampally injected with tau‐AC fibrils, which corresponds to the neuropathological staining and neuronal loss in the brain. These findings identify tau‐AC species as a key neuropathological driver in AD, suggesting novel strategies for therapeutic intervention.


  • Open Access

    Self-aggregating Tau Fragments Recapitulate Pathologic Phenotypes and Neurotoxicity of Alzheimer's Disease in Mice

    by Ly Thi Huong Luu Le, Jeeyoung Lee, Dongjoon Im, Sunha Park, Kyoung-Doo Hwang, Jung Hoon Lee, Yanxialei Jiang, Yong-Seok Lee, Young Ho Suh, Hugh I. Kim, et al.

    In tauopathic conditions, such as Alzheimer's disease (AD), highly soluble and natively unfolded tau polymerizes into an insoluble filament; however, the mechanistic details of this process are not clear. In AD brains, only a small segment of tau forms -helix-stacked protofilaments, while its flanking regions form disordered fuzzy coats. Here, we demonstrated that the tau AD nucleation core (tau-AC) sufficiently induced self-aggregation and recruited full-length tau to filaments. Unexpectedly, phospho-mimetic forms of tau-AC (at Ser324 or Ser356) showed markedly reduced aggregation and seeding propensities. Biophysical analysis revealed that the N-terminus of tau-AC facilitated the fibrillization kinetics, while its phosphorylation induced conformation changes, sterically shielding the nucleation motif. Tau-AC oligomers were efficiently internalized into cells via endocytosis and induced endogenous tau aggregation. In primary hippocampal neurons, tau-AC impaired axon initial segment plasticity upon chronic depolarization and was mislocalized in the somatodendritic compartments. Furthermore, we observed significantly impaired memory retrieval in mice intrahippocampally injected with tau-AC fibrils, which corresponded to the neuropathological staining and neuronal loss in the brain. These findings identified tau-AC species as a key neuropathological driver in AD, suggesting novel strategies for therapeutic intervention.

  • Open Access

    Decoding the Roles of Amyloid-β (1–42)’s Key Oligomerization Domains toward Designing Epitope-Specific Aggregation Inhibitors

    by Dongjoon Im, Soohyeong Kim, Gyusub Yoon, Da Gyeong Hyun, Yu-Gon Eom, Ye Eun Lee, Chang Ho Sohn, Jeong-Mo Choi, Hugh I. Kim